Abstract
Penile carcinoma is a rare and aggressive disease. Its incidence is related with age over 60 and presence of comorbidities such as HPV infection. The higher incidence rate is reached in developing countries. Penile carcinoma is generally a squamous cell carcinoma and it is frequently foregone by a premalignant lesion. Because of its short time to progression, an early detection is mandatory. Good physical examination is the first step toward a correct diagnosis and staging. CT scan and chest X-ray are useful for nodal stage while US and MRI can provide a preoperative assessment of local invasion. Surgical approach depends on invasion and nodal involvement, varying from a local laser ablation to a radical penectomy associated with an inguinal lymphadenectomy. A correct management of nodal disease is crucial to control the penile carcinoma and reduce comorbidities. Systemic chemotherapy could be offered as neoadjuvant treatment in patients with non-resectable nodes and as adjuvant treatment in patients with locally advanced or systemic disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Backes DM, et al. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2009;20:449.
Gunia S, et al. p16(INK4a) is a marker of good prognosis for primary invasive penile squamous cell carcinoma: a multi-institutional study. J Urol. 2012;187:899.
Maden C, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993;85:19.
Teichman JM, et al. Non-infectious penile lesions. Am Fam Physician. 2010;81:167.
Sufrin G, Huben R. Benign and malignant lesion of the penis. In: Jy G, editor. Adult and pediatric urology. 2nd ed. Chicago, IL: Year Book Medical Publisher; 1991. p. 1643.
Hakenberg OW, et al. EAU guidelines Penile. Cancer. 2015;
Ornellas AA, et al. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol. 1994;151:1244–9.
Schlenker B, et al. Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study. Urol Oncol. 2012;30:55.
Bertolotto M, et al. Primary and secondary malignancies of the penis: ultrasound features. Abdom Imaging. 2005;30:108.
Colecchia M, et al. pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy. Anal Quant Cytol Histol. 2009;31:153.
Zou ZJ, et al. Radiocolloid-based dynamic sentinel lymph node biopsy in penile cancer with clinically negative inguinal lymph node: an updated systematic review and meta-analysis. Int Urol Nephrol. 2016;48(12):2001–13. Epub 2016 Aug 30.
Spiess PE, et al. Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlations. J Urol. 2007;177:2157–61.
Catalona WJ. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. J Urol. 1988;140(2):306–10.
Yao K, et al. Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome. J Urol. 2010;184(2):546–52. https://doi.org/10.1016/j.juro.2010.03.140. Epub 2010 Jun 17.
Parra RO, et al. Accurate staging of carcinoma of the penis in men with nonpalpable inguinal lymph nodes by modified inguinal lymphadenectomy. J Urol. 1996;155(2):560–3.
Bouchot O, et al. Morbidity of inguinal lymphadenectomy for invasive penile carcinoma. Eur Urol. 2004;45(6):761–5; discussion 765–6.
Russell CM, et al. Minimally invasive inguinal lymphadenectomy in the management of penile carcinoma. Urology. 2017;106:113–8. https://doi.org/10.1016/j.urology.2017.04.022. Epub 2017 Apr 24.
Pond GR, et al. Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy. Urol Oncol. 2014;32:501.
Gou HF, et al. Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma. PLoS One. 2013;8:e62175.
Zhu Y, et al. Feasibility and activity of sorafenib and sunitinib in advanced penile cancer: a preliminary report. UrolInt. 2010;85:334.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Simonato, A., Scalici Gesolfo, C., Abrate, A. (2021). Cancer of the Penis. In: Russo, A., Peeters, M., Incorvaia, L., Rolfo, C. (eds) Practical Medical Oncology Textbook. UNIPA Springer Series. Springer, Cham. https://doi.org/10.1007/978-3-030-56051-5_50
Download citation
DOI: https://doi.org/10.1007/978-3-030-56051-5_50
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-56050-8
Online ISBN: 978-3-030-56051-5
eBook Packages: MedicineMedicine (R0)